Breast cancers can be classified into distinct subtypes: estrogen receptor positive (ER+), human epidermal growth factor receptor 2 (HER2) amplified, and triple-negative breast cancer (TNBC) defined by the absence of ER and progesterone receptor (PR) expression and HER2 amplification [6]. This evidence concerns the gene ERBB2 and breast cancer.